Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Hohlfeld

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Nature Medicine|December 11, 2012
Ion channels boost axonal injury in multiple sclerosisReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2017
Stop inflammation and you stop neurodegeneration in MS - CommentaryReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Immunologic factors in primary progressive multiple sclerosisReinhard Hohlfeld
Nature Reviews. Neurology|July 14, 2011
Multiple sclerosis: Cladribine--a contentious therapeutic contender for MSReinhard Hohlfeld
The Lancet. Neurology|October 23, 2021
Mesenchymal stem cells for multiple sclerosis: hype or hope?Reinhard Hohlfeld
Journal of Neurology|September 21, 2002
How promising is hematopoetic stem cell transplantation in multiple sclerosis?Reinhard Hohlfeld
Brain : a Journal of Neurology|January 6, 2025
Perceptual rivalry in neuroscience, magic and philosophyReinhard Hohlfeld
Clinical Immunology (Orlando, Fla.)|July 25, 2017
B-cells as therapeutic targets in neuro-inflammatory diseasesReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2009
'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009Reinhard Hohlfeld
JAMA Neurology|April 5, 2016
Alemtuzumab and Multiple Sclerosis: Another Note of CautionReinhard Hohlfeld, Tania Kümpfel
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Nature Medicine|December 11, 2012
Ion channels boost axonal injury in multiple sclerosisReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2017
Stop inflammation and you stop neurodegeneration in MS - CommentaryReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Immunologic factors in primary progressive multiple sclerosisReinhard Hohlfeld
Nature Reviews. Neurology|July 14, 2011
Multiple sclerosis: Cladribine--a contentious therapeutic contender for MSReinhard Hohlfeld
The Lancet. Neurology|October 23, 2021
Mesenchymal stem cells for multiple sclerosis: hype or hope?Reinhard Hohlfeld
Journal of Neurology|September 21, 2002
How promising is hematopoetic stem cell transplantation in multiple sclerosis?Reinhard Hohlfeld
Brain : a Journal of Neurology|January 6, 2025
Perceptual rivalry in neuroscience, magic and philosophyReinhard Hohlfeld
Clinical Immunology (Orlando, Fla.)|July 25, 2017
B-cells as therapeutic targets in neuro-inflammatory diseasesReinhard Hohlfeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2009
'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009Reinhard Hohlfeld
JAMA Neurology|April 5, 2016
Alemtuzumab and Multiple Sclerosis: Another Note of CautionReinhard Hohlfeld, Tania Kümpfel
Pageof 21